Novo Nordisk
NVO
#78
Rank
NZ$368.12 B
Marketcap
NZ$82.85
Share price
-0.27%
Change (1 day)
-54.49%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$46.24 Billion

According to Novo Nordisk's latest financial reports the company has NZ$46.24 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novo Nordisk - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$35.49 B42.25%
2023-12-31$NZ$24.95 B31.79%
2022-12-31$NZ$18.93 B20.08%
2021-12-31$NZ$15.76 B8.7%
2020-12-31$NZ$14.50 B13.15%
2019-12-31$NZ$12.82 B8.29%
2018-12-31$NZ$11.84 B4.71%
2017-12-31$NZ$11.30 B22.2%
2016-12-31$NZ$9.25 B-7.99%
2015-12-31$NZ$10.05 B19.73%
2014-12-31$NZ$8.39 B-12.42%
2013-12-31$NZ$9.59 B9.51%
2012-12-31$NZ$8.75 B4.78%
2011-12-31$NZ$8.35 B-2.25%
2010-12-31$NZ$8.55 B-9.78%
2009-12-31$NZ$9.47 B-11.4%
2008-12-31$NZ$10.69 B29.93%
2007-12-31$NZ$8.23 B8.57%
2006-12-31$NZ$7.58 B18.64%
2005-12-31$NZ$6.39 B-6.12%
2004-12-31$NZ$6.80 B3.45%
2003-12-31$NZ$6.58 B-2.98%
2002-12-31$NZ$6.78 B-9.54%
2001-12-31$NZ$7.49 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
NZ$161.14 B 248.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$41.28 B-10.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$32.19 B-30.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$149.38 B 223.03%๐Ÿ‡ซ๐Ÿ‡ท France